Silver Book Fact

Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.

Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1. AHRQ Web site. http://www.ahrq.gov/clinic/strokcln.htm. Published June 2000

Reference

Title
Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1
Publication
AHRQ
Publication Date
Published June 2000
Authors
Matchar, David, and Gregory Samsa
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same…  
  • Survival rates of patients ages 65-75 with valve repair and replacement
     
  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.  
  • Beta-Blocker Treatment After A Heart Attack: Trends, 1996-2006